Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,981 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leflunomide or methotrexate for juvenile rheumatoid arthritis.
Silverman E, Mouy R, Spiegel L, Jung LK, Saurenmann RK, Lahdenne P, Horneff G, Calvo I, Szer IS, Simpson K, Stewart JA, Strand V; Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group. Silverman E, et al. Among authors: simpson k. N Engl J Med. 2005 Apr 21;352(16):1655-66. doi: 10.1056/NEJMoa041810. N Engl J Med. 2005. PMID: 15843668 Free article. Clinical Trial.
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Weisman MH, Bensen WM, Kaine JL, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Waltuck J, Lindsley HB, Markenson JA, Strand V, Crawford B, Fernando I, Simpson K, Bathon JM. Kremer JM, et al. Among authors: simpson k. Ann Intern Med. 2002 Nov 5;137(9):726-33. doi: 10.7326/0003-4819-137-9-200211050-00007. Ann Intern Med. 2002. PMID: 12416946 Clinical Trial.
Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V. Kremer J, et al. Among authors: simpson k. J Rheumatol. 2004 Aug;31(8):1521-31. J Rheumatol. 2004. PMID: 15290730 Clinical Trial.
Predicting Stroke For Pediatric Patients Supported With Ventricular Assist Devices:A PEDIMACS Report.
Ashfaq A, Lorts A, Rosenthal D, Adachi I, Rossano J, Davies R, Simpson KE, Maeda K, Wisotzkey B, Koehl D, Cantor RS, Jacobs JP, Peng D, Kirklin JK, Morales DLS. Ashfaq A, et al. Among authors: simpson ke. Ann Thorac Surg. 2024 May 25:S0003-4975(24)00386-2. doi: 10.1016/j.athoracsur.2024.05.009. Online ahead of print. Ann Thorac Surg. 2024. PMID: 38802036
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.
Holliday H, Yang J, Dodson E, Nikolic I, Kamili A, Wheatley M, Deng N, Alexandrou S, Davis TP, Kavallaris M, Caldon CE, McCarroll J, De Preter K, Mestdagh P, Marshall GM, Simpson KJ, Fletcher J, Swarbrick A. Holliday H, et al. Among authors: simpson kj. Mol Ther. 2024 May 16:S1525-0016(24)00310-1. doi: 10.1016/j.ymthe.2024.05.008. Online ahead of print. Mol Ther. 2024. PMID: 38759647 No abstract available.
1,981 results